Schaftoside inhibits 3CL(pro) and PL(pro) of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19

It is an urgent demand worldwide to control the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The 3-chymotrypsin-like protease (3CL(pro)) and papain-like protease (PL(pro)) are key targets to discover SARS-CoV-2 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Yang, Zhang, Meng, Xue, Heng, Yu, Rong, Bao, Yang-Oujie, Kuang, Yi, Chai, Yue, Ma, Wen, Wang, Jing, Shi, Xiaomeng, Li, Wenzhe, Hong, Wei, Li, Junhua, Muturi, Elishiba, Wei, Hongping, Wlodarz, Joachim, Roszak, Szczepan, Qiao, Xue, Yang, Hang, Ye, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361578/
https://www.ncbi.nlm.nih.gov/pubmed/35968270
http://dx.doi.org/10.1016/j.apsb.2022.07.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361578/
https://www.ncbi.nlm.nih.gov/pubmed/35968270
http://dx.doi.org/10.1016/j.apsb.2022.07.017

Ejemplares similares